Refine search

Date
Tumour Site
Topics
Congress

126 results for ""

The future of real-world research is now

The future of real-world research is now

ESMO is at the forefront of digital oncology, with some initiatives that support oncologists navigating the emerging opportunities in the field of real-world data research  

The emerging role of ctDNA in breast cancer

The emerging role of ctDNA in breast cancer

Liquid biopsies hold great promise in precision medicine in breast cancer, as shown by the pioneering work of Prof. Nicholas Turner, recipient of the ESMO Award for Translational Research 2023

Three decades of progress in nasopharyngeal cancer

Three decades of progress in nasopharyngeal cancer

Tailored management for high-risk locoregional disease, together with more effective immunotherapy combinations are key areas of exploration in nasopharyngeal cancer, according to 2023 ESMO Lifetime Achievement awardee Prof. Anthony Chan 

Editorial_PrecisionMedicine

Precision oncology – are we at an inflection point?

At Molecular Analysis for Precision Oncology (MAP) Congress 2023, international experts discuss the future of histology-agnostic drug development and clinical trial design

    By
  • Benedikt Westphalen
On Target
Cancer Research

On the horizon of translational research

Tumour agnostic targeted agents and ‘smarter’ dynamic designs are two major areas of interest leading to more patient-centric approaches in cancer care

By Elena Garralda

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.